Fassia M Kasim, Charalel Resmi Ann
Division of Interventional Radiology, Department of Radiology, Weill Cornell Medicine, New York, New York.
Department of Population Health Sciences, Weill Cornell Medicine, New York, New York.
Semin Intervent Radiol. 2024 Mar 14;41(1):16-19. doi: 10.1055/s-0043-1778659. eCollection 2024 Feb.
Yttrium-90 (Y90) radioembolization has become a major locoregional treatment option for several primary and secondary liver cancers. Understanding the various factors that contribute to optimal tumor coverage including sphere count, embolization techniques, and catheter choice is important for all interventional radiologists while planning Y90 dosimetry and delivery. Here, we review these factors and the evidence supporting current practice paradigms.
钇-90（Y90）放射性栓塞已成为多种原发性和继发性肝癌的主要局部区域治疗选择。在规划Y90剂量测定和给药时，了解有助于实现最佳肿瘤覆盖的各种因素，包括微球数量、栓塞技术和导管选择，对所有介入放射科医生来说都很重要。在此，我们回顾这些因素以及支持当前实践模式的证据。
